‹ Screener

WW INTERNATIONAL, INC.

WW · Services-Personal Services · 10.0M shares · +2%/yr ↑ shares · EDGAR filings ↗
Net buyback after stock comp: $1.5B (gross $1.5B, SBC $15M)

Reference price $14.36 · est. market cap ~$144M — last insider purchase, 2026-05-27 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

D48

Recently bankrupt weight-management brand with negative returns being disrupted by GLP-1 alternatives.

Strengths

Risks

Notable findings

Quarterly revenue

2024-09-28 · $193M2024-12-28 · $184M2025-03-29 · $187M2026-03-31 · $168M

Last 4 quarters · from SEC filings.

Key metrics

Revenue growth (QoQ)
-9.8%
Debt / equity
1.5×
Current ratio
1.7×
Tangible book value
-$373M
Cash & investments
$160M

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-05-27DAVIS EUGENE IBuy1.0K$14.36
2026-05-27DAVIS EUGENE IBuy9.0K$14.78
2026-05-26DAVIS EUGENE IBuy1.6K$13.48
2026-05-22DellaFortuna FeliciaBuy1.5K$12.68
2026-05-22DAVIS EUGENE IBuy10K$12.63
2026-05-21Volkmann JonathanBuy1.5K$10.08
2026-05-20Sjoqvist Nikolaj HBuy10K$9.55
2026-05-20Hawks CarneyBuy20K$10.01
2026-01-02Sjoqvist Nikolaj HGrant1.2K
2026-01-02Mason Michael BGrant1.2K
2026-01-02Bornstein JulieGrant1.2K
2026-01-02Hawks CarneyGrant1.2K
2025-12-19Mason Michael BGrant1.2K
2025-12-19Bornstein JulieGrant1.2K
2025-12-19Hawks CarneyGrant1.2K
2025-12-19Sjoqvist Nikolaj HGrant1.2K
2025-11-19Hawks CarneyBuy9.1K$20.81
2025-11-19Hawks CarneyBuy20K$22.75
2025-08-18Haag NicoleSell469$30.86
2025-06-24Comonte TaraOption exercise19K
2025-06-24Comonte TaraDisposition401K
2025-06-24Comonte TaraGrant4.3K
2025-06-24Brown Tracey DDisposition31K
2025-06-24Brown Tracey DGrant329
2025-06-24Semmelbauer ThiloOption exercise26K
2025-06-24Semmelbauer ThiloDisposition76K
2025-06-24Semmelbauer ThiloGrant815
2025-06-24KELLY DENIS FDisposition186K
2025-06-24KELLY DENIS FGrant2.0K
2025-06-24KELLY DENIS FDisposition16K
2025-06-24KELLY DENIS FDisposition6.2K
2025-06-24KELLY DENIS FGrant168
2025-06-24KELLY DENIS FGrant67
2025-06-24Amsel MichaelOption exercise524K
2025-06-24Amsel MichaelTax withheld217K$0.31
2025-06-24Amsel MichaelDisposition307K
2025-06-24Amsel MichaelGrant3.4K
2025-06-24Bornstein JulieDisposition50K
2025-06-24Bornstein JulieGrant533
2025-06-24KELLY DENIS FOption exercise40K
2025-06-24Shrank William HOption exercise21K
2025-06-24Shrank William HDisposition21K
2025-06-24Shrank William HGrant225
2025-06-24Haag NicoleOption exercise1.0K
2025-06-24Haag NicoleOption exercise3.3K
2025-06-24Haag NicoleOption exercise11K
2025-06-24Haag NicoleOption exercise35K
2025-06-24Haag NicoleTax withheld18K$0.31
2025-06-24Haag NicoleDisposition44K
2025-06-24Haag NicoleGrant470
2025-06-24Altschuler StevenOption exercise40K
2025-06-24Altschuler StevenDisposition68K
2025-06-24Altschuler StevenGrant735
2025-06-24Cooke JacquelineOption exercise18K
2025-06-24Cooke JacquelineGrant27K
2025-06-24Cooke JacquelineTax withheld23K$0.31
2025-06-24Cooke JacquelineDisposition28K
2025-06-24Cooke JacquelineGrant295
2025-05-16Haag NicoleOption exercise1.0K
2025-05-16Haag NicoleTax withheld379$0.28
2025-05-15Haag NicoleTax withheld3.1K$0.25
2025-05-15Haag NicoleOption exercise8.6K
2025-05-15Cooke JacquelineOption exercise9.1K
2025-05-15Cooke JacquelineTax withheld4.5K$0.25
2025-03-27Comonte TaraTax withheld36K$0.54
2025-03-27Comonte TaraOption exercise100K
2025-02-27Comonte TaraOption exercise100K
2025-02-27Comonte TaraTax withheld36K$0.80
2025-01-27Comonte TaraOption exercise100K
2025-01-27Comonte TaraTax withheld36K$1.07
2024-12-30Brown Tracey DGrant3.7K
2024-12-30Rice Julie J.Grant3.7K
2024-12-30Bornstein JulieGrant3.7K

All non-derivative Form 4 activity (SEC), newest first.

Clinical trials

TrialTitlePhaseStatusPrimary completion
NCT06605703 ↗A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
Obesity, Overweight
PHASE4Completed2026-02-05
NCT06972277 ↗A Randomized Controlled Trial Comparing the Efficacy of Commercial Weight Management Programs
Obesity and Overweight
NACompleted2026-01-09

Source: ClinicalTrials.gov (U.S. NIH) · active studies first.

Notable events (8-K)

DateItems
2026-06-15Shareholder votefiling ↗
2026-05-15Exec/director changefiling ↗
2026-05-07ResultsExhibitsfiling ↗
2026-04-27Reg FDExhibitsfiling ↗
2026-04-20Exec/director changeReg FDExhibitsfiling ↗
2026-04-17Exec/director changefiling ↗
2026-04-09Exec/director changeReg FDExhibitsfiling ↗
2026-04-07Exec/director changeReg FDExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-152026-06-120001193125-26-271067 ↗
8-K2026-05-152026-05-140001193125-26-226623 ↗
10-Q2026-05-072026-03-310001193125-26-210307 ↗
8-K2026-05-072026-05-070001193125-26-210279 ↗
8-K2026-04-272026-04-270001193125-26-178866 ↗
8-K2026-04-202026-04-190001193125-26-162712 ↗
8-K2026-04-172026-04-130001193125-26-161747 ↗
8-K/A2026-04-092026-04-060001193125-26-148893 ↗
8-K2026-04-072026-04-060001193125-26-144543 ↗
8-K2026-04-032026-03-300001193125-26-141944 ↗
8-K2026-03-162026-03-160001193125-26-107148 ↗
10-K2026-03-162025-12-310001193125-26-107176 ↗